New Licensing Agreement Supports a Maturing Clinical Genomics Infrastructure Landscape.
A recently announced licensing agreement between Genomical and Illumina – two PTA members – signals support for the broader shift in how clinical genomic laboratories are approaching workflow integration and data management.
For accredited clinical laboratories, timely rollout of new genomic tests can be supported through technology-agnostic and vendor-neutral access to multiple genomic analysis software in a cloud-based, and interoperable workflow.
As clinical genomics continues to expand across inherited conditions, cancer diagnostics and population screening programs, the ability to integrate new tools without rebuilding core infrastructure becomes increasingly important.
PTA welcomes developments that reduce implementation barriers, support laboratory accreditation requirements, and strengthen the foundation for secure, scalable, interoperable genomic services in Australia.
Read more in the Genomical Press Release: https://genomical.com.au/app/uploads/2026/03/Media-Release-Genomical-signed-sub-licencing-agreement-with-Illumina.pdf